Date: November 17, 2026

Board Meeting Outcomes

  • The company received listing approvals from both National Stock Exchange of India Limited (NSE) and BSE Limited for 4,78,435 equity shares of ₹10 each allotted to a non-promoter entity on a preferential basis.
  • NSE approval reference: NSE/LIST/58280 dated November 16, 2026
  • BSE approval reference: LOD/PREF/RB/FIP/1121/2026-27 dated November 17, 2026

Financial Results

  • The listed capital of the company will increase to ₹75,60,61,330 (7,56,06,133 fully paid equity shares of ₹10 each) upon completion of this allotment.
  • The distinctive numbers of the allotted shares range from 75127699 to 75606133.

Trading Approval Conditions

  • Trading approval will be granted only after the company submits:
  • Listing approval from NSE (if applicable)
  • Confirmation letters from NSDL/CDSL about crediting shares to beneficiary accounts
  • Confirmation letters from NSDL/CDSL about lock-in of pre-preferential holding (if applicable)
  • The company must apply for trading approval within seven working days from grant of listing approval as per SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023.

Additional Information

  • The disclosure will be hosted on the company's website: www.tegaindustries.com
  • The exchange reserves the right to withdraw approval if submitted information is found incomplete/incorrect/misleading/false or in contravention of regulations.